Table 4

Literature review of ophthalmological findings in patients with LS

AuthorJournalYearCases (n)Locus of mutationPtosisStrabismus*NystagmusOAPR
Grover et al9Am J Ophthalmol19702NA0/20/21/22/20/2
Howard et al8Am J Opthalmol197265NA2/6526/65‡17/6518/65NA
Calcić et alJ Child Neurol20011NI in mtDNA and SURF11/11/11/10/10/1
Nesbitt et alDev Med Child Neurol201216MT-ND3 (m.10191T>C)NANA2/164/16NA
Kirby et al§Ann Neurol20033MT-ND5 (m.13513G>A)0/11/10/11/10/1
Sudo et al18J Hum Genet20046MT-ND5 (m.13513G>A)5/63/6NA2/4NA
Ruiter et alEur J Hum Genet20072MT-ND5 (m.13513G>A)1/22/22/22/2NA
Brautbar et alMol Genet Metab20085MT-ND5 (m.13513G>A)2/43/3NA1/4NA
Leshinsky et alJ Child Neurol201118MT-ND6 (m.14487T>C)NANANA4/18NA
Fanhnehjelm et alActa Ophthalmol20121MT-ND6 (m.14487T>C)0/11/1NA0/10/1
Hayashi et alOphthalmology20001MT-ATP6 (m.8993T>G)0/10/10/11/10/1
West et alJ Pediatr Ophthalmol Strabismus20091SURF10/11/11/1NANA
Rahman et al3Ann Neurol199635Heterogeneous6/3512/3516/3512/35NA
Gronlund et al10Br J Opthalmol201012Heterogeneous0/123/123/124/120/12
Ma et alJ Clin Neurosci201375Heterogeneous3/752/754/75NANA
This report44Heterogeneous7/4418/446/449/399/39
Total27/249 (10.8%)72/248 (29.0%)52/254 (20.5%)60/201 (29.9%)9/57 (15.8%)
  • *Strabismus was assessed together with ophthalmoplegia or reduced ocular motility.

  • †These cases were from the literature review in the article.

  • ‡One case in this report had esotropia initially, but spontaneous consecutive exotropia developed later. Ten cases were exotropia, six cases were esotropia, two cases were not specified, and others were ophthalmoplegia.

  • §There were three cases in this article. Among them, one case was from Rahman et al3 and another case did not have ophthalmologic information.

  • ¶Two cases were reported in this article, but another patient had not been fully evaluated due to poor cooperation. Therefore it was excluded from analysis.

  • x/y, x is the number of patients with this clinical features, y is the number of patients for whom information regarding this clinical feature was available.

  • LS, Leigh syndrome; mtDNA, mitochondrial DNA; NA, not available; NI, not identified; OA, optic atrophy; PR, pigmentary retinopathy; SURF1, surfeit locus protein 1.